BioVaxys Faces Volatility as VaxMite Targets Malaria Breakthroughs
Explore BioVaxys’ journey: Canada’s biotech firm tackles malaria vaccine VaxMite amid volatile stock, regulatory hurdles, and a bold quest to transform global health.
3 minutes to read